An observational study in Maternal-Fetal Relations, Depression and Anxiety, sponsored by Yildiz Atadag. Completed at 1 site in Turkey. Open to female participants. Per ClinicalTrials.gov, last updated 2017-11-30.
Sponsored by Yildiz Atadag · Observational
Among 340 studies in Depression with a site in Turkey — 59 open to participants now, 70 under way, none of them phase 3. Depression · Turkey.
Among the 340 studies in Depression with a site in Turkey, this one is the 63rd largest by enrollment of the 96 observational ones, is one of 4 that started in 2016, is one of 96 observational ones, and was the 10th registered.
8,577 studies on the registry are indexed under Depression; 1,720 are open to participants now.
This study's enrollment of 73 is below the median of 175 across 1,257 observational studies indexed under Depression.
Browse Depression studies →59 of the 340 studies in Depression with a site in Turkey are open now, in 1 country. Each count lists the studies.
Of the 1,088 Depression studies recruiting now, 469 (43%) set no upper age limit and 519 (48%) stop at 75 or younger; 203 take children under 18; 310 take healthy volunteers.
This study: female.
The full table on the hub →340 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 4 started in 2016.
Median enrollment 60 across the 244 interventional studies, 105 across the 96 observational. Of the 256 that completed or were terminated, 6 (2%) have results posted.
6 of 340 have an industry lead sponsor. The 10 most frequent:
Yildiz Atadag is the lead sponsor of 2 studies on the registry; none are open to participants now.
Yildiz Atadag has 1 study filed under Depression — fewer than ten, so there is no comparison to draw.
25 of the studies in Depression with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07846410Istanbul Physical Medicine Rehabilitation Training and Research HospitalVirtual Reality-Based Hypnotherapy for Pain, Sleep, and Mood in Spinal Cord Injury | 2026-11 |
| NCT07444697Kırıkkale University"Erectile Function After PCI in MI and Non-MI Patients" | 2026-11 |
| NCT07171944Koç UniversityEffects of Artificial Intelligence Nurse Orientation Program on Psychological Outcomes and Length of Hospital Stay in Intensive Care Unit | 2026-11-01 |
| NCT07906119Saglik Bilimleri UniversitesiAcceptance and Commitment Therapy-Based Group Psychotherapy for Chronic Headache | 2026-11-19 |
| NCT07517549Ordu UniversitySexual Health Education During Pregnancy | 2026-11-30 |
Among the 340 studies in Depression with a site in Turkey, from their registry updates:
Maternal bonding was described as a qualitative change in the relationship of a mother with her infant. By this study, the investigators aimed to investigate the mother-infant bonding and the factors affecting it, from the point of the family practice, which is responsible for the healthcare of all family members from the fetus to the eldest individual in a family.
The study was carried out as a single-centered descriptive research among 73 women at the postpartum period. The sociodemographic status and the histories of pregnancies of the study participants were recorded. The Maternal Attachment Inventory (MAI), which questions the biological, psychological and social factors, and the Hospital Anxiety and Depression Scale (HADS) were used to collect data to determine the factors affecting the mother-infant bonding in the postpartum period.
The study is a descriptive survey study, which was conducted to determine the mother-infant attachment and its affecting factors in mothers in the first 6-week of the postpartum period. In order to conduct the study, the local Ethics Committee approval was obtained. (Approval date: 24.11.2016, number 18517).
The mean score of the Turkish version of the Maternal Attachment Inventory (MAI) is approximately 95+6 according to the validation study. In our study, considering that the average MAI score of the participants would be approximately 97, investigators determined to include 73 patients in the study with a type I error set at a=0.05 and with the power of (1-b) 80%.
The universe of the study consists of the mothers in the first 6 weeks of the postpartum period presenting to the Obstetrics and Gynecology Clinic and the mothers of the pediatric patients presenting to the Pediatric Clinic of the Health Sciences University Umraniye Education and Research Hospital.
The universe of the study consists of the mothers in the first 6 weeks of the postpartum period presenting to the Obstetrics and Gynecology Clinic and the mothers of the pediatric patients presenting to the Pediatric Clinic of the Health Sciences University Umraniye Training and Research Hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Women who had gave birth in 6 weeks
Maternal Attachment Inventory
The items of the MAI are designed in the 4-point Likert scale, which can be scored between 1 and 4 (1: never, 2: sometimes, 3: often, 4: always). The increasing scores indicate increasing levels of attachment of the mother.
Time frame: 20 minutes
Ran from Dec 2016 to primary completion in Feb 2017, 2 months.
Of 460 non-industry observational studies under Depression, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 63. This study's 2 months is below that.
Counting every sponsor, half of 493 studies reached it within 33 months; a quarter within 13 and three quarters within 62.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yildiz Atadag